Skin Neurofibroma — Trials

Skin Neurofibroma — Trials · CancerIndex

Clinical trials

Registered studies

9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05005845	NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)	completed	Phase 2	199	NFlection Therapeutics, Inc.INDUSTRY	1	Feb 17, 2026	clinicaltrials
NCT04730583	Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas	completed	Phase 1	34	Massachusetts General HospitalOTHER	1	Feb 21, 2025	clinicaltrials
NCT05438290	DPCP to Treat Cutaneous Neurofibromas Associated With NF1	completed	Phase 1	17	Nicholas GulatiOTHER	1	May 6, 2024	clinicaltrials
NCT02839720	Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma	completed	Phase 2	11	National Cancer Institute (NCI)NIH

Data updated 22 days agoSource updated Feb 17, 2026source: clinicaltrials